• 1. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 5. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyranopyrimidines

Comprehensive Overview of 2,4-Dichloro-8-phenyl-7,8-dihydro-5H-pyrano[4,3-D]pyrimidine (CAS No. 1263868-77-4)

The compound 2,4-Dichloro-8-phenyl-7,8-dihydro-5H-pyrano[4,3-D]pyrimidine (CAS No. 1263868-77-4) is a heterocyclic organic molecule with significant potential in pharmaceutical and agrochemical research. Its unique structure, featuring a pyrano[4,3-D]pyrimidine core, makes it a valuable scaffold for drug discovery and development. Researchers are increasingly interested in this compound due to its versatile reactivity and potential applications in designing novel therapeutic agents.

In recent years, the demand for heterocyclic compounds like 2,4-Dichloro-8-phenyl-7,8-dihydro-5H-pyrano[4,3-D]pyrimidine has surged, driven by advancements in medicinal chemistry and the need for innovative small-molecule drugs. The compound's dichloro-substituted pyrimidine moiety is particularly noteworthy, as it enhances binding affinity to biological targets, a feature highly sought after in kinase inhibitor development. This aligns with current trends in precision medicine and targeted cancer therapies, where such scaffolds play a pivotal role.

The synthetic versatility of CAS 1263868-77-4 allows for diverse modifications, making it a favorite among chemists exploring structure-activity relationships (SAR). Its phenyl group at the 8-position introduces lipophilicity, which can improve membrane permeability—a critical factor in drug bioavailability. This characteristic has sparked discussions in online forums and research communities about optimizing lead compounds for central nervous system (CNS) penetration, a hot topic in neurodegenerative disease research.

From a technical perspective, the pyrano-pyrimidine framework exhibits remarkable stability under physiological conditions, addressing a common challenge in prodrug design. Analytical studies using HPLC and mass spectrometry confirm its high purity (>98%), meeting stringent requirements for preclinical studies. These qualities have positioned 2,4-Dichloro-8-phenyl-7,8-dihydro-5H-pyrano[4,3-D]pyrimidine as a reference standard in several academic and industrial laboratories.

Environmental considerations also come into play with this compound. Unlike persistent organic pollutants, CAS 1263868-77-4 demonstrates favorable biodegradation profiles in preliminary ecotoxicity assessments. This aspect resonates with growing industry emphasis on green chemistry principles and sustainable molecular design—a subject frequently queried in scientific search engines.

Ongoing investigations explore the compound's potential as a building block for fluorescent probes, leveraging its conjugated system for bioimaging applications. Such interdisciplinary uses reflect broader trends in combining chemical biology with materials science, answering frequent researcher queries about multifunctional molecular tools.

In conclusion, 2,4-Dichloro-8-phenyl-7,8-dihydro-5H-pyrano[4,3-D]pyrimidine represents a compelling case study in modern heterocyclic chemistry. Its balanced properties—synthetic accessibility, structural diversity, and biological relevance—make it a compound of enduring interest across multiple scientific domains. As research continues to uncover new applications, this molecule will likely remain at the forefront of innovative therapeutic and technological developments.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)